Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Congenital Adrenal Hyperplasia

10 trials tracked for Congenital Adrenal Hyperplasia: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 82 citations.

10Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 3 Phase 2 6 Phase 1 1
  1. Phase 3 Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia Completed · 82 cited
  2. Phase 3 A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH Completed · 82 cited
  3. Phase 3 Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia Completed
  4. Phase 2 Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia Completed
  5. Phase 2 A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia Completed
  6. Phase 2 Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH Completed
Show 4 more trials
  1. Phase 2 Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia Completed
  2. Phase 2 Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia Completed
  3. Phase 2 Dexamethasone Treatment of Congenital Adrenal Hyperplasia Completed
  4. Phase 1 Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systemic glucocorticoid exposure in children linked to reversible myocardial hypertrophy, subclinical cardiac changes
Diabetes & Endocrinology Sys. Review
Systemic glucocorticoid exposure in children linked to reversible myocardial hypertrophy, subclinical cardiac changes Review finds reversible heart changes in children taking certain steroid medications
A narrative review of pediatric systemic glucocorticoid exposure found the most consistent structural signal is time-locked, reversible myoc…
Certain steroid medicines used for childhood illnesses can temporarily thicken the heart muscle in very young babies, but this change appear…
Frontiers Apr 9, 2026
Systematic review evaluates molecular diagnostic evolution for congenital adrenal hyperplasia diagnosis
Diabetes & Endocrinology Sys. Review
Systematic review evaluates molecular diagnostic evolution for congenital adrenal hyperplasia diagnosis Long-read sequencing shows promise for diagnosing congenital adrenal hyperplasia with high accuracy
This systematic review examined the evolution of molecular diagnostic strategies for congenital adrenal hyperplasia due to 21-hydroxylase de…
Long-read genetic sequencing now matches standard tests and finds hidden gene changes that older methods miss, improving diagnosis for conge…
Frontiers Apr 6, 2026